ALEXANDRIA, Va., Aug. 6 -- United States Patent no. 12,377,090, issued on Aug. 5, was assigned to X4 Pharmaceuticals Inc. (Boston).
"Methods for treating neutropenia" was invented by E. Lynne Kelley (Boston) and Sarah Cohen (Boston).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to methods of treating patients with neutropenia, such as severe, chronic neutropenia, or a related disorder, in which mavorixafor, or a pharmaceutically acceptable salt thereof, is administered to such patients. In some cases, the methods have the advantage of reducing or eliminating the need for administration of G-CSF, which is frequently associated with severe bone pain."
The patent was filed on Marc...